Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Institutional market share decreases about every day, according to fintel.io
Date Market Share (%) Funds Flow (%)
2022-09-21 0.0258
2022-09-20 0.0263
2022-09-19 0.0279
2022-09-16 0.0275
2022-09-15 0.0280
2022-09-14 0.0291
2022-09-13 0.0291
2022-09-12 0.0293
2022-09-09 0.0300
2022-09-08 0.0301
2022-09-07 0.0305
2022-09-06 0.0290
2022-09-02 0.0296
2022-09-01 0.0277
2022-08-31 0.0274
2022-08-30 0.0276
2022-08-29 0.0273
2022-08-26 0.0273
2022-08-25 0.0278
2022-08-24 0.0284
Why does Slilaty and Camille have all these shell companies like TRT Pharma Inc, Mountain West Business Solutions which traded as MWBN..is there more?
Dumpster fire in progress before raid, fire sale on 4th floor of 6500 trans Canada highway. S hit da fan.
I wonder if Aegis Capital is still in this.
Wow. This may not just delist, it might get a DTCC frozen. It went to almost -15%
Dr Shitty still playing with mice..mice is dead but mummified to collect data. Shitty want to milk investors more with his cure for cancer banner, he need new gadget may be space ride.
If it helps at all 4.47% is still institutional on the nasdaq website. Not impressive by any means. Dumpster fire in progress
lol..this goes on forever on SunshineBio1's twitter.
Replying to
@SunshineBio1
So so article… but you let stock value dip 750% since the reversal— sad you can’t gain any stock momentum and it’s not like you even care - original shareholders have been discarded like common pieces of household trash.
Replying to
@SunshineBio1
What happened to xenograft mice studies ? What happened to unknown partner from Montreal ? What happened to UGA mice studies ? You said you will end pandemic … give us an update on that. You are on nasdaq and Twitter… world is watching. $abfm
@SunshineBio1
Replying to
@SunshineBio1
$sbfm always said they don't have money to start Phase 1 but now they have $42M cash in hand but still no progress
Sep 19
Jeez! How much more $ do they need???
Replying to
@SunshineBio1
3rd last tweet- 64 replies, previous tweet -12 replies, now 6…. People have moved on. Longs liquidated. They will do this again in 8 years
Replying to
@SunshineBio1
When is this trash company going to make a difference in the world? Straight garbage
Replying to
@SunshineBio1
Anyone home?
Down 24,000 dollars on this stock. Smh. Praying to break Even and get as far away from this as possible. Worst investment I ever made.
Replying to
@SunshineBio1
Why not release a PR and give some results to your loyal shareholders?
Replying to
@SunshineBio1
no update about Adva-27a since march 2021
Replying to
@SunshineBio1
What happened to lab results of testing at uga ? Remember transgenic mice 18 months back ? Are they still alive or died ?
@SunshineBio1
Replying to
@SunshineBio1
Dr Slilaty, it's time for you to come out and do an interview to explain to us shareholders everything that has been going on. Including your shortcomings to me that would be transparency. $SBFM you can do better!
Replying to
@SunshineBio1
first you R/S with 200 then listed on nasdaq @ shareholder expense then 2 offering still dont give us any update whats going on since 1 year and you claim working for 15 hours per day and you still using #transparency shame
Replying to
@SunshineBio1
Speculation is that after another 6 months you say the same thing like you did last 18 months .. When can you prove them wrong?
Replying to
@SunshineBio1
Hey $SBFM, Perhaps we can get an official PR with some real meat and potatoes? Like, an actual update on the progress and plan/timetable for your scientific studies? That would be Great.
Replying to
@SunshineBio1
Thank you for the confirmation, it is greatly appreciated. But you can start using that hash tag once you lay all your cards out and let us know exactly how the trials are going and when they'll end...
Nice Paid ad—- maybe drop a real press release— if it’s too hard hire someone to do it.
@SunshineBio1
Replying to
@SunshineBio1
All you fucks will be arrested soon kiss the wife and kids good bye, you’ll be sleeping next to these guys for awhile, Biden hates scammers he paid us more money (FBI) to come get you all
Replying to
@SunshineBio1
Slilaty and Camille…you morons better start buying millions of shares or announce some fucking news. You’re about to get your asses delisted
Replying to
Replying to
@SunshineBio1
FBI will be arresting you guys soon stop with the fluff prs $12 to $1 you stole it’s that simple now jail
@SunshineBio1
Fuck you Canadian scum
#1 Scam on the Nasdaq trending triple Cherries
pos is trending on the front page of ihub too with few posts here. Lmao
See you all at @ .10 this week= .0001 triple cherries
Delisting short if no transparency
Brett Rosen is obviously pissed at SBFM and suing OPTI by reading his Twitter and then there is this tweet:
“
I had a great talk with the attorneys investigating $OPTI yesterday and have a follow up on Friday to finalize some details! After that there will be a website and a link to sign up to be a plaintiff on the law firm’s website! Stay tuned, more to come… $OPT”
And this retweet from Brett:
.81 = .004
I hope these crooks get the same treatment as the Father of Microarray, Dr. Mark Schena at Arrayit Corp.
That's 6 (!) institutional investors that have bailed (one with 1 share left but I counted them anyway) and one that bet AGAINST Sunshine as a short. I think that’s the correct total. Lordy
A short was the way to go apparently
Someone should call these people and see if they'll say anything.
Proequities, Inc. closes position in US8677814035 / Sunshine Biopharma Inc
UBS Group AG reports 99.96% decrease in ownership of US8677814035 / Sunshine Biopharma Inc
Jane Street Group, Llc closes position in US8677814035 / Sunshine Biopharma Inc
Security US8677814035 / Sunshine Biopharma Inc
Institution Jane Street Group, Llc
Latest Disclosed Ownership 0 shares
Latest Disclosed Value $ 0
Related SBFM / Sunshine Biopharma, Inc.
Armistice Capital, Llc closes position in US8677814035 / Sunshine Biopharma Inc
Security US8677814035 / Sunshine Biopharma Inc
Institution Armistice Capital, Llc
Manager Steven Boyd
Latest Disclosed Ownership 0 shares
Latest Disclosed Value $ 0
Related SBFM / Sunshine Biopharma, Inc.
Hudson Bay Capital Management LP closes position in US8677814035 / Sunshine Biopharma Inc
Security US8677814035 / Sunshine Biopharma Inc
Institution Hudson Bay Capital Management LP
Latest Disclosed Ownership 0 shares
Latest Disclosed Value $ 0
Related SBFM / Sunshine Biopharma, Inc.
Hudson Bay Capital Management LP closes position in US8677814035 / Sunshine Biopharma Inc
2022-08-12 - Hudson Bay Capital Management LP has filed a 13F-HR form disclosing ownership of 0 shares of Sunshine Biopharma Inc (US:US8677814035) with total holdings valued at $0 USD as of 2022-06-30. Hudson Bay Capital Management LP had filed a previous 13F-HR on 2022-05-16 disclosing 315,000 shares of Sunshine Biopharma Inc at a value of $720,000 USD. This represents a change in shares of -100.00 percent and a change in value of -100.00 percent during the quarter.
Empery Asset Management, LP closes position in US8677814035 / Sunshine Biopharma Inc
Security US8677814035 / Sunshine Biopharma Inc
Institution Empery Asset Management, LP
Manager Ryan Matthew Lane and Martin David Hoe
Latest Disclosed Ownership 0 shares
Latest Disclosed Value $ 0
Related SBFM / Sunshine Biopharma, Inc.
Empery Asset Management, LP closes position in US8677814035 / Sunshine Biopharma Inc
2022-08-12 - Empery Asset Management, LP has filed a 13F-HR form disclosing ownership of 0 shares of Sunshine Biopharma Inc (US:US8677814035) with total holdings valued at $0 USD as of 2022-06-30. Empery Asset Management, LP had filed a previous 13F-HR on 2022-05-16 disclosing 450,450 shares of Sunshine Biopharma Inc at a value of $1,104,000 USD. This represents a change in shares of -100.00 percent and a change in value of -100.00 percent during the quarter.
Next update should be about 9-30, right?
That will show us the most current up to date of who has left and who has not.
Institutional Owners 0 total, 0 long only, 0 short only, 0 long/short - change of % MRQ Shares Outstanding shares (source: Capital IQ)
I saw that and I don’t think that’s correct hold on let me see what it shows me
Whatever happened in March-ish, or early this year seems to have re-shifted and caused the company to focus on vitamins.
Look at the first 4 or 5 pages at https://sunshinebiopharma.com
All but two articles since April are vitamins as latest news.
They aren’t saying anything else. I don’t think these institutional investors signed onboard for a GNC knock off, tho they did go into into BK protection in 2020 lol.
https://fintel.io/so/us/sbfm shows 0 now for institutional ownership
Fintel.io. There are others too, last I checked 3 fully checked out, 1 sold all but 1 share and one institutional investor decided to take a short position.
How do you know the institutions sold?
Jail for Camille Sebaaly & his partner in crime Dr. Snake oil sales man Steve Slilaty
Common Causes For Essential Amino Acids Deficiency
Sunshinebiopharma
Sep 20, 2022
3 Min Read
If you want to ensure that you have all the essential amino acids that your body needs, buying amino acids online is the best and easiest way to avoid developing…
Really well written, right on the main page today of https://sunshinebiopharma.com
Right in line with this paid promo release from 8/30/22, addresses none of the recent concerns.
Sunshine Biopharma's Essential 9 Supplement Marks The Pharma Company's Entry Into $152 Billion Dietary Supplement Market
by
Rachael Green
August 30, 2022 8:45 AM | 4 min read
https://www.benzinga.com/general/biotech/22/08/28684230/sunshine-biopharmas-essential-9-supplement-marks-the-pharma-companys-entry-into-152-billion-dieta
SBFM right now is probably the hottest potentially scam stock around.
They decided to focus on vitamins today and not address anything else.
No one is talking because so many eyes are watching. Not just investor eyes.
SBFMs website today literally pivoted from covid and adva-27a to vitamins, which they are licensed to sell.
https://sunshinebiopharma.com/common-causes-for-essential-amino-acids-deficiency/
http://www.stocksequity.com/active-stocks/seducing-stocks-scisparc-ltd-nasdaqsprc-8-65-sunshine-biopharma-inc-nasdaqsbfm-2-70/
Seducing stocks: SciSparc Ltd. (NASDAQ:SPRC -8.65%), Sunshine Biopharma, Inc. (NASDAQ:SBFM -2.70%)
Sunshine Biopharma, Inc. (NASDAQ:SBFM)’s Analysis & Performances to Discover
Sunshine Biopharma, Inc., belongs to Healthcare sector and Drug Manufacturers – Specialty & Generic industry. The company’s total Outstanding Shares of 18.89M. SBFM flaunted -2.70% to reach at $0.86 during previous trading session. The company has experienced volume of 109,240 shares while on average the company has a capacity of trading 1.09M share.
Observing the Technical Indicators:
Sunshine Biopharma, Inc. institutional ownership is held at 4.00% while insider ownership was 0.80%. As of now, SBFM has a P/S, P/E and P/B values of 41.89, 0 and 0.33 respectively. Its P/Cash is valued at 0.40.
The Company’s net profit margin for the 12 months at 0. Comparatively, the gazes have a Gross margin 47.30%.
Profitability ratios:
Looking into the profitability ratios of SBFM stock, an investor will find its ROE, ROA, ROI standing at -38.10%, -34.30% and -605.80%, respectively.
Reading RSI Indicator
Sunshine Biopharma, Inc. (SBFM) attained alert from day Traders as RSI reading reached at 24.18. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. Traditionally, and according to Wilder, RSI is considered overbought when above 70 and oversold when below 30. Signals can also be generated by looking for divergences, failure swings, and centerline crossovers. RSI can also be used to identify the general trend. These traditional levels can also be adjusted to better fit the security or analytical requirements. Raising overbought to 80 or lowering oversold to 20 will reduce the number of overbought/oversold readings. Short-term traders sometimes use 2-period RSI to look for overbought readings above 80 and oversold readings below 20.
Earnings per Share Details of Sunshine Biopharma, Inc.:
The EPS of SBFM is strolling at -1.60, measuring its EPS growth this year at -74.50%. As a result, the company has an EPS growth of 0 for the approaching year.
Given the importance of identifying companies that will ensure earnings per share at a tall rate, we later obsession to umpire how to identify which companies will achieve high amassing rates. One obvious showing off to identify high earnings per portion count together companies are to locate companies that have demonstrated such build up beyond the p.s. 5 to 10 years.
What Does the Payout Ratio Tell You?
The payout ratio is a key financial metric used to determine the sustainability of a company’s dividend payments. It is the amount of dividends paid to shareholders relative to the total net income of a company.
Formula for the Payout Ratio Is
“Payout Ratio = Dividends / Earnings”
Is It Overvalued? Look at the Payout Ratio of SPRC, SBFM
The payout ratio shows the proportion of earnings paid out as dividends to shareholders, typically expressed as a percentage of the company’s earnings.
The payout ratio can also be expressed as dividends paid out as a proportion of cash flow.
The payout ratio is also known as the dividend payout ratio.
SPRC has a Payout Ratio of 0 and SBFM has a Payout Ratio of 0.
You’ve misunderstood the point. A molecular scientist can shoot up mice or cells. Write research papers on what he did to those mice and cells.
That requires a PhD, a doctorate in philosophy which has zero to do with medicine for humans. Only a medical doctor can. But I don’t really care about that.
It’s nothing in comparison to everything else, worry about why institutional investors have left or took a short position.
That is where the problem is.
Out of all those institutions, only one bet against them and look where the stock is.
I forgot to mention, Blackstone Investment Funds, as an institutional investor, looks good on paper.
But they bet against Sunshine. At this point they are over the moon.
Blackstone Alternative Investment Funds is gonna make a lot of cash with just 45 shorted shares, provided they can or already did unload. Maybe not a lot but a huge profit margin percentage.
The next filing is going to be very telling.
I don’t know how all this works but 4 institutions completely left, UBS sold everything except 1 share worth about 85 cents, so may as well make it 5.
It really comes down to this. How many have really left? We will know soon.
All studies are supposed to be done by the different universities, he is not the one conducting them as you know
It’s a good thing. He can now inject mice at Universities and do research studies. Not allowed to make any medical opinions because he ain’t no medical doctor.
It’s a good thing. He can now inject mice at Universities and do research studies. Not allowed to make any medical opinions because he ain’t no medical doctor.
It's a research degree in molecular biology, it has nothing to with philosophy ??
Institutional investors ran out the door tells me plenty about what is going on here. I would love to know what they found out, that made them all get out asap.
Roadshow I’m sure was a bust also .
UBS Group sold off, down to 1 share from March
UBS Group AG 2,434 30 Mar 2022 0.00% 2,092
Date Source Investor Type Avg Share Price Paid (Est) Shares Shares Changed (%) Reported Value (&1000) Value Changed (%)
2022-08-10 13F UBS Group AG 1 -99.96 0 -100.00
Date Source Investor Type Avg Share Price Paid (Est) Shares Shares Changed (%) Reported Value (&1000) Value Changed (%)
2022-05-31 NP Blackstone Alternative Investment Funds - Blackstone Alternative Multi-Strategy Fund Class Short -45 -0
SUNSHINE BIOPHARMA INC - SBFM
Short sale restricted for 2022-09-20
https://www.shortablestocks.com/?SBFM
He is PHD (and not a medical doctor) meaning Doctor of Philosophy, I guess every one knows this, a doctorate in any discipline except medicine , or sometimes theology
He happens to have PHD is molecular biology, but not a medical doctor.
Lol they turned off DMs on Twitter. Won’t respond to any of the hundreds of tweets since July.
laugh emoji & popcorn..
I didn’t think SBFM would be this much fun
Anyway, adva-27a and their patents from way back when were the only assets they have. It's in the SEC filings. Nothing else has any real value. Now they got some cash.
They got those assets, essentially adva-27a to be valued at 1 billion. Got uplisted, and here we are. Why did 4 stock institutions pull out? I think that pdf presentation from back in March spelled out exactly what it did to me.
But it's all junk. Those stupid disclaimers and whatever, let them do as they please.
Buddy as much I as loathe and agree these management style has not been forthcoming I disagree on the education thing.
We see this on his LinkedIn , unless he is … or his account is not real
Bachelors of Science -- Cornell University (Genetics & Biochemistry)
Ph.D. -- University of Arizona (Molecular Biology)
I pulled it right out of their own pdf.
Management team
"Steve N.Slilaty, Ph.D."
It's literally just all crap unless they can get things approved and to phase I.
".......... I realized Steve Slilaty is not a medical doctor.
Only a doctor of philosophy. That’s a 3 or 4 year course."
Wow! Where did you get that from? Do you just make things up as you go? Just open the link you posted, scroll down (until the end this time) and you will notice Slilaty is a molecular biologist! What a fudmaster!!!
I can see a couple problems with this March 2022 presentation, when at least one institutional investor bailed. No idea why any bailed but the timing is interesting and 4 up and bailed. Sold everything.
Sunshine Biopharma Presentation – March 2022
https://investors.sunshinebiopharma.com/assets/Sunshine%20Biopharma_Presentation%2020220308_Updated_FINAL%20(2).pdf
Look at Upcoming Milestones. I realized Steve Slilaty is not a medical doctor.
Only a doctor of philosophy. That’s a 3 or 4 year course.
Specifically this bothers me:
Upcoming Milestones
Adva-27a Drug Development Program:
? GMP Manufacturing (5 Kilograms)
? IND-Enabling Studies
? Filing of IND Application (“Fast-Track” anticipated)
? Phase I Clinical Trials (Pancreatic Cancer, Jewish General Hospital)
Antiviral Program:
? Efficacy Studies in Coronavirus Infected Mice
? GMP Manufacturing (5 Kilograms)
? Filing of IND Application (“Fast-Track” anticipated)
? Phase I Clinical Trials (University of Georgia Affiliate Hospital)
Supplements:
? Large-Scale Marketing
? Expansion beyond US and Canada
Look also at R&D Pipeline. Adva-27a worth in excess of 1 billion and time to Phase 1: 9-18mos. Covid same thing, but multi-billion. This is great, but not much has happened except a mice and some research studies in all these years.
How many times are they going anticipate filing? They’ve put out several PRs, the first around mid 2020 about FDA fast track and patent priority filing.
And the forward looking statement? Maybe that’s regular boiler plate legalese, but it says this at the very top:
Sunshine Biopharma Inc. does not intend, and does not assume any obligation, to update these “forward-looking statements” except as required by law. These “forward-looking statements” involve risks and uncertainties relating to, among other things, results of and sale activities, uninsured risks, regulatory changes, availability of production facilities, timeliness of government approvals and the granting of permits and licenses, changes in prices, actual operating and financial performance of facilities, equipment and processes relative to specifications and expectations. Actual results may differ materially from those expressed or implied by such “forward-looking statements.”
Followers
|
757
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
113861
|
Created
|
10/27/08
|
Type
|
Free
|
Moderators |
SUNSHINE BIOPHARMA INC
ANTI CANCER DRUGS
ANTI CORONA VIRUS RESEARCH
SBFM Transfer Agent
Corporate Stock Transfer
3200 Cherry Creek Dr. South
Suite 430
Denver, CO 80209
(303) 282 - 4800 p
(303) 282 - 5800 f
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |